Apira Science, Inc. Accelerates Global Growth Through Exclusive Distribution...
IRVINE, Calif. Apira Science, Inc. has named China Central Pharmaceuticals Ltd. its exclusive distributor of the iGrow® Hair Growth System in the Chinese market. The partnership highlights Apira’s...
View ArticleAsian Football Confederation to Protect Players against Sudden Cardiac Arrest...
CHELMSFORD, Mass. ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Asian Football Confederation (AFC) has purchased ZOLL AED Plus®...
View ArticleWomen Make Science More Creative
Smart Multimedia Gallery ‘Reflections’ by Maria Iordanous: the ‘most preferred artwork’, attracting 45% of the vote (Photo: Business Wire) View and Share Photo Download Small LONDON EMBARGOED UNTIL...
View Article頭痛治療のエレクトロコア製非侵襲VNS装置が最近の米国頭痛学会(AHS)年次スコッツデール頭痛シンポジウムと第17回北米神経調節学会(NANS)年次大会で注目
米ニュージャージー州バスキングリッジ (ビジネスワイヤ) — 群発頭痛および片頭痛の予防と治療に使用するエレクトロコアの非侵襲迷走神経刺激(VNS)装置について、AHS年次スコッツデール頭痛シンポジウム(11月21~24日)と今週のNANS大会(12月5~8日)でいずれも検討されました。...
View Article~アルツハイマー病の克服に向けた包括的なアプローチに更なる一手~大塚製薬とルンドベック社、アルツハイマー病ワクチン「Lu AF20513」の共同開発の契約締結
東京 (ビジネスワイヤ) — 大塚製薬株式会社(本社:東京都千代田区、代表取締役社長:岩本太郎、以下「大塚製薬」)とH. ルンドベックA/S(本社:デンマーク、コペンハーゲン、CEO:ウルフ・ウインバーグ、以下「ルンドベック社」)は、アルツハイマー型認知症に対して研究中のワクチン候補である「Lu AF20513」を共同開発することについて本日合意しました。...
View ArticleLundbeck and Otsuka to Co-Develop a Vaccine, Lu AF20513, Their Third...
VALBY, Denmark & TOKYO H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced that they will further expand their collaboration to include the development of Lu...
View ArticleLincor Solutions升级患者参与技术,推出新产品组合
爱尔兰科克 –(美国商业资讯)–Lincor Solutions今日宣布推出新产品组合,向医院和卫生系统提供其业内领先的患者参与技术。Lincor的LINC产品组合搭载新一代技术,可在单一平台上访问临床、管理和娱乐系统,该新产品组合提供一系列便于实施的解决方案,以期提高患者满意度,改善临床疗效,减少不必要的再次住院,并促进电子病历(EHR)的推广采用。...
View ArticleIroko Pharmaceuticals Enters into Strategic Agreements to Expand...
PHILADELPHIA Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that its affiliate, Iroko Pharmaceuticals Inc.,...
View ArticleIroko Pharmaceuticals签署战略性协议,拓展ZORVOLEX™(双氯芬酸)在美国以外的商业化
费城 (美国商业资讯)–Iroko Pharmaceuticals, LLC是一家致力于推动镇痛科学的全球性专科制药公司,该公司今天宣布,其分公司Iroko Pharmaceuticals Inc.已经与Algorithm SAL和PT Pratapa Nirmala...
View Article昆泰任命Scott Evangelista领导整合型商业服务和解决方案部门
Smart Multimedia Gallery 昆泰任命Scott Evangelista领导整合型商业服务和解决方案部门。(照片:美国商业资讯) View and Share Photo Download Small 北卡罗来纳州研究三角园区 (美国商业资讯)–昆泰(Quintiles)今天宣布任命W. Scott...
View Articleイロコ・ファーマシューティカルズが戦略的契約を締結し、ZORVOLEXTM(ジクロフェナク)の販売を米国外に拡大へ
フィラデルフィア (ビジネスワイヤ) — 鎮痛科学の前進に専心する世界的スペシャリティー製薬会社のイロコ・ファーマシューティカルズLLC は本日、系列会社のイロコ・ファーマシューティカルズ株式会社が、Algorithm SALおよびPT Pratapa...
View ArticleWright Medical Group, Inc. Provides Date of MicroPort Shareholder Meeting to...
ARLINGTON, Tenn. Wright Medical Group, Inc. (NASDAQ: WMGI) today reported it has been advised by MicroPort Scientific Corporation (HK: 0853) that the Hong Kong Stock Exchange has granted clearance...
View ArticleAmpliPhi Biosciences Announces $18 Million Private Placement
RICHMOND, VA. & COLWORTH, England & SYDNEY AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug...
View Article世界最大級のナノテクノロジー総合展「nano tech 2014」 開催
Smart Multimedia Gallery nano tech 2013 会場風景 (写真:ビジネスワイヤ) View and Share Photo Download Small 東京 (ビジネスワイヤ) — nano tech 実行委員会(委員長:大阪大学 川合知二教授)は、来る2014 年1 月29 日~31日の3 日間、東京ビッグサイトにて、“nano tech 2014”...
View ArticleThe World’s Largest Nanotechnology Exhibition & Conference: “nano tech 2014″...
Smart Multimedia Gallery A view from the ‘nano tech 2013′ venue (Photo: Business Wire) View and Share Photo Download Small TOKYO The nano tech Executive Committee (Chairman: Osaka University...
View ArticleBiogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF...
CAMBRIDGE, Mass. & SEOUL, Korea Biogen Idec (NASDAQ: BIIB) and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to...
View ArticleInnate Immunotherapeutics Completes $10M IPO
SYDNEY Innate Immunotherapeutics is pleased to announce it has successfully raised A$10 million through its Initial Public Offer (IPO) and will immediately commence planning its clinical trial for...
View ArticleRoche and Genentech Acquire Unlimited Access to Open Monoclonal Technology’s...
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche...
View Article